Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report contains market size and forecasts of Liposome Drug Delivery in global, including the following market information:
Global Liposome Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Liposome Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Vial)
Global top five Liposome Drug Delivery companies in 2021 (%)
The global Liposome Drug Delivery market was valued at 3842.1 million in 2021 and is projected to reach US$ 8627 million by 2028, at a CAGR of 12.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomal Doxorubicin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposome Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposome Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, by Type, 2021 (%)
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
Global Liposome Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, by Application, 2021 (%)
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
Global Liposome Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Vial)
Global Liposome Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposome Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Liposome Drug Delivery revenues share in global market, 2021 (%)
Key companies Liposome Drug Delivery sales in global market, 2017-2022 (Estimated), (K Vial)
Key companies Liposome Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
Liposome Drug Delivery Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Liposome Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposome Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposome Drug Delivery Overall Market Size
2.1 Global Liposome Drug Delivery Market Size: 2021 VS 2028
2.2 Global Liposome Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Liposome Drug Delivery Sales: 2017-2028
3 Company Landscape
3.1 Top Liposome Drug Delivery Players in Global Market
3.2 Top Global Liposome Drug Delivery Companies Ranked by Revenue
3.3 Global Liposome Drug Delivery Revenue by Companies
3.4 Global Liposome Drug Delivery Sales by Companies
3.5 Global Liposome Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Liposome Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Liposome Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposome Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposome Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposome Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposome Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposome Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposome Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Liposome Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global Liposome Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposome Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global Liposome Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global Liposome Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global Liposome Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Liposome Drug Delivery Market Size, 2021 & 2028
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposome Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposome Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Liposome Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global Liposome Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposome Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global Liposome Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global Liposome Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global Liposome Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Liposome Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Liposome Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposome Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Liposome Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global Liposome Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposome Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global Liposome Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global Liposome Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Liposome Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America Liposome Drug Delivery Sales, 2017-2028
6.4.3 US Liposome Drug Delivery Market Size, 2017-2028
6.4.4 Canada Liposome Drug Delivery Market Size, 2017-2028
6.4.5 Mexico Liposome Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Liposome Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe Liposome Drug Delivery Sales, 2017-2028
6.5.3 Germany Liposome Drug Delivery Market Size, 2017-2028
6.5.4 France Liposome Drug Delivery Market Size, 2017-2028
6.5.5 U.K. Liposome Drug Delivery Market Size, 2017-2028
6.5.6 Italy Liposome Drug Delivery Market Size, 2017-2028
6.5.7 Russia Liposome Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries Liposome Drug Delivery Market Size, 2017-2028
6.5.9 Benelux Liposome Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Liposome Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia Liposome Drug Delivery Sales, 2017-2028
6.6.3 China Liposome Drug Delivery Market Size, 2017-2028
6.6.4 Japan Liposome Drug Delivery Market Size, 2017-2028
6.6.5 South Korea Liposome Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia Liposome Drug Delivery Market Size, 2017-2028
6.6.7 India Liposome Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Liposome Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America Liposome Drug Delivery Sales, 2017-2028
6.7.3 Brazil Liposome Drug Delivery Market Size, 2017-2028
6.7.4 Argentina Liposome Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposome Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Liposome Drug Delivery Sales, 2017-2028
6.8.3 Turkey Liposome Drug Delivery Market Size, 2017-2028
6.8.4 Israel Liposome Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia Liposome Drug Delivery Market Size, 2017-2028
6.8.6 UAE Liposome Drug Delivery Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Corporate Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposome Drug Delivery Major Product Offerings
7.1.4 Gilead Sciences Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 Gilead Sciences Key News
7.2 Pacira
7.2.1 Pacira Corporate Summary
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposome Drug Delivery Major Product Offerings
7.2.4 Pacira Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Pacira Key News
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Corporate Summary
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposome Drug Delivery Major Product Offerings
7.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Sun Pharmaceutical Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposome Drug Delivery Major Product Offerings
7.4.4 Johnson & Johnson Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposome Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau
7.6.1 Sigma-Tau Corporate Summary
7.6.2 Sigma-Tau Business Overview
7.6.3 Sigma-Tau Liposome Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Sigma-Tau Key News
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Corporate Summary
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposome Drug Delivery Major Product Offerings
7.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 Ipsen (Onivyde) Key News
7.8 CSPC
7.8.1 CSPC Corporate Summary
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposome Drug Delivery Major Product Offerings
7.8.4 CSPC Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 CSPC Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposome Drug Delivery Major Product Offerings
7.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 Teva Pharmaceutical Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposome Drug Delivery Major Product Offerings
7.10.4 Novartis Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Corporate Summary
7.11.2 Fudan-Zhangjiang Liposome Drug Delivery Business Overview
7.11.3 Fudan-Zhangjiang Liposome Drug Delivery Major Product Offerings
7.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Fudan-Zhangjiang Key News
8 Global Liposome Drug Delivery Production Capacity, Analysis
8.1 Global Liposome Drug Delivery Production Capacity, 2017-2028
8.2 Liposome Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposome Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposome Drug Delivery Supply Chain Analysis
10.1 Liposome Drug Delivery Industry Value Chain
10.2 Liposome Drug Delivery Upstream Market
10.3 Liposome Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposome Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Liposome Drug Delivery in Global Market
Table 2. Top Liposome Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Liposome Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Liposome Drug Delivery Revenue Share by Companies, 2017-2022
Table 5. Global Liposome Drug Delivery Sales by Companies, (K Vial), 2017-2022
Table 6. Global Liposome Drug Delivery Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Liposome Drug Delivery Price (2017-2022) & (USD/Vial)
Table 8. Global Manufacturers Liposome Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposome Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposome Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Liposome Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Liposome Drug Delivery Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Liposome Drug Delivery Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Liposome Drug Delivery Sales (K Vial), 2017-2022
Table 15. By Type - Global Liposome Drug Delivery Sales (K Vial), 2023-2028
Table 16. By Application - Global Liposome Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Liposome Drug Delivery Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Liposome Drug Delivery Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Liposome Drug Delivery Sales (K Vial), 2017-2022
Table 20. By Application - Global Liposome Drug Delivery Sales (K Vial), 2023-2028
Table 21. By Region - Global Liposome Drug Delivery Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Liposome Drug Delivery Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Liposome Drug Delivery Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Liposome Drug Delivery Sales (K Vial), 2017-2022
Table 25. By Region - Global Liposome Drug Delivery Sales (K Vial), 2023-2028
Table 26. By Country - North America Liposome Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Liposome Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Liposome Drug Delivery Sales, (K Vial), 2017-2022
Table 29. By Country - North America Liposome Drug Delivery Sales, (K Vial), 2023-2028
Table 30. By Country - Europe Liposome Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Liposome Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Liposome Drug Delivery Sales, (K Vial), 2017-2022
Table 33. By Country - Europe Liposome Drug Delivery Sales, (K Vial), 2023-2028
Table 34. By Region - Asia Liposome Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Liposome Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Liposome Drug Delivery Sales, (K Vial), 2017-2022
Table 37. By Region - Asia Liposome Drug Delivery Sales, (K Vial), 2023-2028
Table 38. By Country - South America Liposome Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Liposome Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Liposome Drug Delivery Sales, (K Vial), 2017-2022
Table 41. By Country - South America Liposome Drug Delivery Sales, (K Vial), 2023-2028
Table 42. By Country - Middle East & Africa Liposome Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Liposome Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Liposome Drug Delivery Sales, (K Vial), 2017-2022
Table 45. By Country - Middle East & Africa Liposome Drug Delivery Sales, (K Vial), 2023-2028
Table 46. Gilead Sciences Corporate Summary
Table 47. Gilead Sciences Liposome Drug Delivery Product Offerings
Table 48. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 49. Pacira Corporate Summary
Table 50. Pacira Liposome Drug Delivery Product Offerings
Table 51. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 52. Sun Pharmaceutical Corporate Summary
Table 53. Sun Pharmaceutical Liposome Drug Delivery Product Offerings
Table 54. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 55. Johnson & Johnson Corporate Summary
Table 56. Johnson & Johnson Liposome Drug Delivery Product Offerings
Table 57. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 58. Luye Pharma Corporate Summary
Table 59. Luye Pharma Liposome Drug Delivery Product Offerings
Table 60. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 61. Sigma-Tau Corporate Summary
Table 62. Sigma-Tau Liposome Drug Delivery Product Offerings
Table 63. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 64. Ipsen (Onivyde) Corporate Summary
Table 65. Ipsen (Onivyde) Liposome Drug Delivery Product Offerings
Table 66. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 67. CSPC Corporate Summary
Table 68. CSPC Liposome Drug Delivery Product Offerings
Table 69. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 70. Teva Pharmaceutical Corporate Summary
Table 71. Teva Pharmaceutical Liposome Drug Delivery Product Offerings
Table 72. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Liposome Drug Delivery Product Offerings
Table 75. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 76. Fudan-Zhangjiang Corporate Summary
Table 77. Fudan-Zhangjiang Liposome Drug Delivery Product Offerings
Table 78. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$, Mn) and Average Price (USD/Vial) (2017-2022)
Table 79. Liposome Drug Delivery Production Capacity (K Vial) of Key Manufacturers in Global Market, 2020-2022 (K Vial)
Table 80. Global Liposome Drug Delivery Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Liposome Drug Delivery Production by Region, 2017-2022 (K Vial)
Table 82. Global Liposome Drug Delivery Production by Region, 2023-2028 (K Vial)
Table 83. Liposome Drug Delivery Market Opportunities & Trends in Global Market
Table 84. Liposome Drug Delivery Market Drivers in Global Market
Table 85. Liposome Drug Delivery Market Restraints in Global Market
Table 86. Liposome Drug Delivery Raw Materials
Table 87. Liposome Drug Delivery Raw Materials Suppliers in Global Market
Table 88. Typical Liposome Drug Delivery Downstream
Table 89. Liposome Drug Delivery Downstream Clients in Global Market
Table 90. Liposome Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liposome Drug Delivery Segment by Type
Figure 2. Liposome Drug Delivery Segment by Application
Figure 3. Global Liposome Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Liposome Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposome Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. Liposome Drug Delivery Sales in Global Market: 2017-2028 (K Vial)
Figure 8. The Top 3 and 5 Players Market Share by Liposome Drug Delivery Revenue in 2021
Figure 9. By Type - Global Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 10. By Type - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Type - Global Liposome Drug Delivery Price (USD/Vial), 2017-2028
Figure 12. By Application - Global Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 13. By Application - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 14. By Application - Global Liposome Drug Delivery Price (USD/Vial), 2017-2028
Figure 15. By Region - Global Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 16. By Region - Global Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 17. By Country - North America Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 18. By Country - North America Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 19. US Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 24. Germany Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. France Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 33. China Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. India Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 39. By Country - South America Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 40. Brazil Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Liposome Drug Delivery Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Liposome Drug Delivery Sales Market Share, 2017-2028
Figure 44. Turkey Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Liposome Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 48. Global Liposome Drug Delivery Production Capacity (K Vial), 2017-2028
Figure 49. The Percentage of Production Liposome Drug Delivery by Region, 2020 VS 2027
Figure 50. Liposome Drug Delivery Industry Value Chain
Figure 51. Marketing Channels
Global Gold Nanoparticles Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 121
Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 109
Market Overview of Global High Volume Subcutaneous Drug Delivery market:
According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a dee......
Global Gold Nanoparticles Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period.
The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
Global Liposome Drug Delivery Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 123
According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period.
The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 127
According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
Global Liposomes Drug Delivery Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 117
According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 129
According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period.
Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 160
Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body.
Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 135
Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body.
Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
